Halothane
Fluothane (halothane) is a small molecule pharmaceutical. Halothane was first approved as Fluothane on 1982-01-01. It is used to treat status asthmaticus in the USA. The pharmaceutical is active against potassium channel subfamily K member 9 and potassium channel subfamily K member 10. In addition, it is known to target potassium channel subfamily K member 12, potassium channel subfamily K member 2, potassium channel subfamily K member 3, potassium channel subfamily K member 5, potassium channel subfamily K member 13, potassium voltage-gated channel subfamily B member 1, and G protein-activated inward rectifier potassium channel 2.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Halothane
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
FLUOTHANE | Wyeth | N-011338 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
status asthmaticus | — | D013224 | — |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
1 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
General anesthesia | D000768 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | HALOTHANE |
INN | halothane |
Description | Halothane is a haloalkane comprising ethane having three flouro substituents at the 1-position as well as bromo- and chloro substituents at the 2-position. It has a role as an inhalation anaesthetic. It is a haloalkane, an organofluorine compound, an organochlorine compound and an organobromine compound. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | FC(F)(F)C(Cl)Br |
Target
Agency Approved
KCNK9
KCNK9
KCNK10
KCNK10
Organism
Homo sapiens
Gene name
KCNK9
Gene synonyms
TASK3
NCBI Gene ID
Protein name
potassium channel subfamily K member 9
Protein synonyms
Acid-sensitive potassium channel protein TASK-3, potassium 2-pore domain leak channel TASK3, potassium channel, two pore domain subfamily K, member 9, TWIK-related acid-sensitive K(+) channel 3, TWIK-related acid-sensitive K+ 3, Two pore K(+) channel KT3.2, Two pore potassium channel KT3.2
Uniprot ID
Mouse ortholog
Kcnk9 (223604)
potassium channel subfamily K member 9 (Q3LS21)
Alternate
KCNK12
KCNK12
KCNK2
KCNK2
KCNK3
KCNK3
KCNK5
KCNK5
KCNK13
KCNK13
KCNB1
KCNB1
KCNJ6
KCNJ6
Organism
Homo sapiens
Gene name
KCNK12
Gene synonyms
NCBI Gene ID
Protein name
potassium channel subfamily K member 12
Protein synonyms
potassium channel, subfamily K, member 12, potassium channel, two pore domain subfamily K, member 12, Tandem pore domain halothane-inhibited potassium channel 2, tandem pore domain potassium channel THIK-2, THIK-2
Uniprot ID
Mouse ortholog
Kcnk12 (210741)
potassium channel subfamily K member 12 (Q76M80)
Variants
Clinical Variant
Identifier | Target mutation | Effect | Evaluation | Status |
---|---|---|---|---|
VCV000575733 | CACNA1S, 520C>T, Arg174Trp | drug response | 2021-03-24 | 1A |
VCV000017626 | CACNA1S, 3257G>A, Arg1086His | drug response | 2021-03-24 | 1A |
VCV000012984 | RYR1, 14545G>A, Val4849Ile | drug response | 2021-03-24 | 1A |
VCV000012972 | RYR1, 7373G>A, Arg2458His | drug response | 2021-03-24 | 1A |
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 23,950 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
208 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more